Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Guo, Wei  [Clear All Filters]
2024
Ding SJ, Liao HP, Huang FM, Chen L, Guo W, Feng KY, Huang T, Cai Y-D. Analyzing domain features of small proteins using a machine-learning method. Proteomics. 2024:e2300302.
Dai Q, Zhu J, Yang J, Zhang C-Y, Yang W-J, Pan B-S, Yang X-R, Guo W, Wang B-L. Construction of a Cancer Stem Cell related Histone Acetylation Regulatory Genes Prognostic Model for Hepatocellular Carcinoma via Bioinformatics Analysis: Implications for Tumor Chemotherapy and Immunity. Curr Stem Cell Res Ther. 2024.
Ma QL, Chen L, Feng KY, Guo W, Huang T, Cai Y-D. Exploring Prognostic Gene Factors in Breast Cancer via Machine Learning. Biochem Genet. 2024.
Pei Y, Guo Y, Wang W, Wang B, Zeng F, Shi Q, Xu J, Guo L, Ding C, Xie X, et al. Extracellular vesicles as a new frontier of diagnostic biomarkers in osteosarcoma diseases: a bibliometric and visualized study. Front Oncol. 2024;14:1359807.
Huang FM, Guo W, Chen L, Feng KY, Huang T, Cai Y-D. Identifying Autophagy-Associated Proteins and Chemicals with a Random Walk-Based Method within Heterogeneous Interaction Network. Front Biosci (Landmark Ed). 2024;29(1):21.
Gregorich ZR, Zhang Y, Kamp TJ, Granzier H, Guo W. Mechanisms of RBM20 Cardiomyopathy: Insights From Model Systems. Circ Genom Precis Med. 2024:e004355.
2023
Yuan M, Hu X, Xing W, Wu X, Pu CX, Guo W, Zhu XY, Yao M, Ao L, Li Z, et al. B2M is a biomarker associated with immune infiltration in High altitude pulmonary edema. Comb Chem High Throughput Screen. 2023.
Wang A, Guo W, Damiani D, Sumbly V, Goyal G, Du Z, Bai O. B-cell prolymphocytic leukemia with P53 abnormalities successfully treated with bendamustine and rituximab: a report of three cases. Transl Cancer Res. 2023;12(7):1873-1882.
Yu Z, Guo W, Ma X, Zhang B, Dong P, Huang L, Wang X, Wang C, Huo X, Yu W, et al. Correction: Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells. Mol Cancer. 2023;22(1):144.
Wang B, Guo Y, Xu J, Zeng F, Ren T, Guo W. Efficacy of bone defect therapy involving various surface treatments of titanium alloy implants: an in vivo and in vitro study. Sci Rep. 2023;13(1):20116.
Li S, Wang Q, Duan X, Pei Z, He Z, Guo W, Han L. A glutathione-responsive PEGylated nanogel with doxorubicin-conjugation for cancer therapy. J Mater Chem B. 2023.
Ren JX, Gao Q, Zhou XC, Chen L, Guo W, Feng KY, Huang T, Cai Y-D. Identification of key gene expression associated with quality of life after recovery from COVID-19. Med Biol Eng Comput. 2023.
Yuan F, Ren JX, Liao HP, Guo W, Chen L, Feng KY, Huang T, Cai Y-D. Identification of Whole-Blood DNA Methylation Signatures and Rules Associated with COVID-19 Severity. Front Biosci (Landmark Ed). 2023;28(11):284.
Lin X, Ma QL, Chen L, Guo W, Huang Z, Huang T, Cai Y-D. Identifying genes associated with resistance to KRAS G12C inhibitors via machine learning methods. Biochim Biophys Acta Gen Subj. 2023:130484.
Chen Z, Yao M-W, Shen Z-L, Li S-D, Xing W, Guo W, Li Z, Wu X-F, Ao L-Q, Lu W-Y, et al. Interferon-gamma and tumor necrosis factor-alpha synergistically enhance the immunosuppressive capacity of human umbilical-cord-derived mesenchymal stem cells by increasing PD-L1 expression. World J Stem Cells. 2023;15(8):787-806.
Wang R, Yu W, Zhu T, Lin F, Hua C, Ru L, Guo P, Wan X, Xue G, Guo Z, et al. MED27 plays a tumor-promoting role in breast cancer progression by targeting KLF4. Cancer Sci. 2023.
Hao J, Huang J, Hua C, Zuo Y, Yu W, Wu X, Li L, Xue G, Wan X, Ru L, et al. A novel TOX3-WDR5-ABCG2 signaling axis regulates the progression of colorectal cancer by accelerating stem-like traits and chemoresistance. PLoS Biol. 2023;21(9):e3002256.
Zhan Z, Guo W, Wan X, Bai O. Second primary malignancies in non-Hodgkin lymphoma: epidemiology and risk factors. Ann Hematol. 2023.
2022
Guo P, Zu S, Han S, Yu W, Xue G, Lu X, Lin H, Zhao X, Lu H, Hua C, et al. BPTF inhibition antagonizes colorectal cancer progression by transcriptionally inactivating Cdc25A. Redox Biol. 2022;55:102418.
Zheng W-J, Wang P-X, Sun Y-F, Cheng J-W, Zhong Y-C, Xu Y, Guo W, Hu B, Zhou J, Fan J, et al. Uncovering the Heterogeneity and Clinical Relevance of Circulating Tumor-Initiating Cells in Hepatocellular Carcinoma Using an Integrated Immunomagnetic-Microfluidic Platform. ACS Appl Mater Interfaces. 2022.
2021
Guo W, Zhang C, Wang X, Dou D, Chen D, Li J. Resolving the difference between left-sided and right-sided colorectal cancer by single-cell sequencing. JCI Insight. 2021.
Li W, Hu S, Tian C, Wan X, Yu W, Guo P, Zhao F, Hua C, Lu X, Xue G, et al. TRIP4 transcriptionally activates DDIT4 and subsequent mTOR signaling to promote glioma progression. Free Radic Biol Med. 2021.
2020
Li Z, Song Y, Yuan P, Guo W, Hu X, Xing W, Ao L, Tan Y, Wu X, Ao X, et al. Antibacterial Fusion Protein BPI21/LL-37 Modification Enhances the Therapeutic Efficacy of hUC-MSCs in Sepsis. Mol Ther. 2020.
Jiang W, Yan Y, Chen M, Luo G, Hao J, Pan J, Hu S, Guo P, Li W, Wang R, et al. Aspirin enhances the sensitivity of colon cancer cells to cisplatin by abrogating the binding of NF-κB to the COX-2 promoter. Aging (Albany NY). 2020;12.
Zhang H, Wang J, Ren T, Huang Y, Liang X, Yu Y, Wang W, Niu J, Guo W. Bone marrow mesenchymal stem cell-derived exosomal miR-206 inhibits osteosarcoma progression by targeting TRA2B. Cancer Lett. 2020.

Pages